MedTrace Logo

Postoperative subQ Pain Control for Spinal Fusion Surgery

NCT03476811 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2022-05-26

No results posted yet for this study

Summary

Post-operative pain following lumbar spine fusion is frequently difficult to manage and can lead to increased doses of opiate pain medications to control pain. In this study, the use of subcutaneous local anesthesia will be studied to determine its efficacy at reducing post-operative pain following spinal fusion surgery.

Conditions

  • Spine Fusion
  • Surgery
  • Pain, Postoperative

Interventions

DRUG

0.25% Marcaine at 2ml/hr and pain medications

Subcutaneous pain control with OnQ Subcutaneous Drug pump

DEVICE

Placement of OnQ Drug pump

Subcutaneous placement of OnQ drug pump with normal saline infusion

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-09
Primary Completion
2021-06-30
Completion
2021-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03476811 on ClinicalTrials.gov